POS-011 THE EFFECT IN RENAL FUNCTION AND VASCULAR DECONGESTION IN TYPE 1 CARDIORENAL SYNDROME TREATED WITH TWO STRATEGIES OF DIURETICS, A RANDOMIZED CLINICAL TRIAL
Main Authors: | J. Chavez Iñiguez, A. De la Torre-Quiroga, A. Aranda G de Quevedo, A. Romero-Muñoz, J. Gómez-Fregoso, G. García-García |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921001637 |
Similar Items
-
Decongestion: Diuretics and other therapies for hospitalized heart failure
by: Ali Vazir, et al.
Published: (2016-04-01) -
FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
by: Devy Deliyanti, et al.
Published: (2015-01-01) -
Topical decongestants in otorhinolaryngologist practice
by: A. A. Krivopalov, et al.
Published: (2021-01-01) -
Topical decongestants: myth and reality
by: N. A. Miroshnichenko, et al.
Published: (2018-07-01) -
Long-acting topical decongestants
by: A. Yu. Ovchinnikov, et al.
Published: (2020-11-01)